Effective Management Strategies for Dental Patients on Anticoagulants: Ensuring Optimal Care and Patient Safety: An Overview

Anticoagulants are essential for healing damaged blood arteries because they prevent blood from clotting. They disrupt the body’s normal balance and reduce the risk of thromboembolic episodes. For many illnesses and medical problems, extended therapy for four weeks or more is necessary. Some research has compared the risk of continuing anticoagulant medication with bleeding and embolic consequences in patients on anticoagulants. Patients with a therapeutic INR of less than 4 are more likely to continue taking anticoagulants, which carry a 1% risk of serious embolic consequences compared to a 0.2% chance of major bleeding. Therefore, individuals taking dabigatran, rivaroxaban, or apixaban should consult their treating physician before having dental work done. When treating patients using anticoagulants, dentists and doctors should collaborate to ensure that the patient’s INR is within the therapeutic range.